Zoetis Inc (ZTS) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Zoetis Inc   (NYSE: ZTS)
 

Zoetis Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZTS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -0.38 % 14.14 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) -3.12 % -1.07 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 1.42 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) -0.09 % 2.69 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 7.24 % 7.52 % 8.67 % 13.63 %


ZTS's Growth Comparisons in III. Quarter 2026




Although the Major Pharmaceutical Preparations industry saw advancing Revenue by 14.14%, Zoetis Inc announced -0.38% year on year sales decline in the third quarter 2026, to $ 2.39 billions, and underperformed the 10.18% Revenue improvement in the Healthcare sector. Comparing the third quarter, sales Zoetis Inc was trailing overall market not just Major Pharmaceutical Preparations industry.

Top-line fell by -3.12% from the second quarter. Average annual sales growth for Zoetis Inc is 7.24%, while S & P 500's average yearly sales increase is 13.63%, including only Businesses with the third quarter 2026 financial results.

ZTS Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
United States
172.47 %
52.89 %
Australia
229.89 %
56.83 %
Brazil
207 %
59.07 %
Canada
207.14 %
48.28 %
Chile
265.52 %
47.22 %
China
313.33 %
48.8 %
France
185 %
48.05 %
Germany
188.71 %
39.84 %
Italy
125.71 %
0 %
Japan
200 %
-
Mexico
251.22 %
51.58 %
Spain
215.79 %
44.58 %
United Kingdom
174.39 %
50 %
Other developed markets
228.66 %
51.4 %
Other emerging markets
253.07 %
43.75 %
Total geographical area
196.17 %
50.49 %
Contract Manufacturing and Human Health Diagnostics
-
55.77 %
Companion Animal
-
48.5 %
Livestock
210.07 %
54.93 %
Dogs and Cats
188.08 %
48.49 %
Horses
237.88 %
48.67 %
Cattle
206.02 %
56.14 %
Swine
224.32 %
50 %
Poultry
221.7 %
46.35 %
Fish
216.67 %
65.77 %
Parasiticides
229.79 %
44.86 %
Vaccines
218.55 %
51.92 %
Dermatology
142.58 %
53.28 %
Anti-infective Products
-
58.14 %
Pain & Sedation
-
47.62 %
Other pharmaceuticals
-
52.15 %
Animal health diagnostics
234.55 %
53.33 %
Other Non Pharmaceuticals
-
50 %
Total products and services
196.17 %
50.49 %
Total
-0.38 %
-3.12 %


Growth Rates of ZTS's Income in the third quarter 2026


ZTS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 4.19 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) - -23.95 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) -54.03 % 30.81 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) -36.68 % -2.24 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 9.58 % 14.12 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -18.03 % -16.85 % -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -14.47 % -26.31 % -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -6.22 % 6.33 % 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -4.97 % -9.97 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 10.32 % 14.58 % 8.91 % -28.64 %

ZTS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -18.03 % -17.47 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) -14.47 % 21.94 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) -5.48 % 5.05 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) -4.97 % -10.2 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth 10.32 % 14.16 % 9.09 % 23.95 %

ZTS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -11.66 % -31.09 % -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -12.73 % -35.27 % -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 0.68 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -3.11 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 11.88 % -0.46 % 8.91 % -28.64 %



ZTS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -11.66 % -31.6 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) -12.73 % 7.1 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -3.11 % 0.05 % 10.63 % 4.93 %
EPS Net 5 Year Avg. Change 11.97 % 14.16 % 9.09 % 23.95 %



Zoetis Inc saw it's income per share fall by -11.66% from the same quarter a year ago, in the third quarter, Zoetis Inc was still better off than the Major Pharmaceutical Preparations industry reporting -31.6%, and less than -39.2% slide in the Healthcare sector. Slow third quarter 2026 income per share in Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in Zoetis Inc 's results, which underperformed overall market.

Sequentially company's EPS fell by -12.73% from the second quarter results. . Looking into annual growth, income per share grew by 11.97% on average in last five years, while S & P 500's including only Businesses with the third quarter 2026 reports, average yearly income per share growth is 23.95%.

ZTS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -10.93 % 25.56 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 33.27 % -29.98 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) 1.7 % 12.34 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -3.72 % 3.59 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change 6.15 % 0.88 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change -27.92 % 29.88 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -19.55 % 18.43 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) -8.55 % -21.14 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) -26.78 % 15.46 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) -4.99 % 1.83 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change 6.51 % 7.84 % 8.61 % 14.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.